Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Eagle Pharmaceuticals Earnings Conference Call Is Coming Up, Here's What You Need To Know

Eagle Pharmaceuticals (NASDAQ:EGRX) will host a conference call at 08:30 AM ET on May 9, 2022, to discuss Q1 2022 earnings results.

Benzinga

5 AMD Analysts Weigh In On Blowout Q1 Earnings: Why 2 Reduced Price Targets

Advanced Micro Devices, Inc. (NASDAQ: AMD) reported first-quarter earnings after the bell on Tuesday.

Benzinga

Etsy Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Etsy. Looking at options history for Etsy (NASDAQ:ETSY) we detected 17 strange trades.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

NVIDIA Whale Trades For May 04

A whale with a lot of money to spend has taken a noticeably bearish stance on NVIDIA. Looking at options history for NVIDIA (NASDAQ:NVDA) we detected 18 strange trades.

Benzinga

Recap: Manitex International Q1 Earnings

Manitex International (NASDAQ:MNTX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:31 AM. Here's what investors need to know about the announcement.

Benzinga

How To Attend Lincoln Educational Servs Q1 2022 Earnings Conference Call

Lincoln Educational Servs (NASDAQ:LINC) will host a conference call at 10:00 AM ET on May 9, 2022, to discuss Q1 2022 earnings results.

Benzinga

Myriad Genetics's Earnings: A Preview

Myriad Genetics (NASDAQ:MYGN) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Myriad Genetics will report an earnings per share (EPS) of $-0.07.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Earnings Preview: AVEO Pharmaceuticals

AVEO Pharmaceuticals (NASDAQ:AVEO) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that AVEO Pharmaceuticals will report an earnings per share (EPS) of $-0.25.

Benzinga

Hain Celestial Group Earnings Preview

Hain Celestial Group (NASDAQ:HAIN) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Hain Celestial Group will report an earnings per share (EPS) of $0.45.

Benzinga

What Are Whales Doing With Microsoft

Someone with a lot of money to spend has taken a bearish stance on Microsoft (NASDAQ:MSFT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

13 Analysts Have This to Say About Caesars Entertainment

Caesars Entertainment (NASDAQ:CZR) has observed the following analyst ratings within the last quarter:

Benzinga

Mid-Morning Market Update: Markets Mixed; Nasdaq Tumbles 100 Points

U.S. stocks traded mixed this morning, with the Nasdaq dropping more than 100 points on Wednesday.

Benzinga

What Are Whales Doing With Tesla

Someone with a lot of money to spend has taken a bearish stance on Tesla (NASDAQ:TSLA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Earnings Preview: Papa John's International

Papa John's International (NASDAQ:PZZA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Papa John's International will report an earnings per share (EPS) of $0.94.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Here's How Much You Would Have Made Owning Digital Turbine Stock In The Last 5 Years

Digital Turbine (NASDAQ:APPS) has outperformed the market over the past 5 years by 79.55% on an annualized basis producing an average annual return of 91.28%. Currently, Digital Turbine has a market capitalization of $3.10 billion.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022

Upgrades

Benzinga

Robinhood Allows Users To Lend Stock: What Investors Need To Know

Discount broker Robinhood Markets Inc (NASDAQ: HOOD) has announced it will begin allowing users to earn income on the stocks they own by lending out their shares.

Benzinga

Lyft Stock Drives Off A Cliff Following Q1 Earnings Print: Here's Where To Watch For The Bounce

Lyft, Inc (NASDAQ: LYFT) was trading down over 26% in the premarket on Wednesday after printing its first-quarter earnings after the market close on Tuesday.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Looking Into Biogen's Return On Capital Employed

According to Benzinga Pro, during Q1, Biogen (NASDAQ:BIIB) earned $218.50 million, a 1165.85% increase from the preceding quarter. Biogen's sales decreased to $2.53 billion, a 7.39% change since Q4.

Benzinga

SPS Commerce's Return On Capital Employed Overview

According to Benzinga Pro data SPS Commerce (NASDAQ:SPSC) posted a 1.27% decrease in earnings from Q4. Sales, however, increased by 2.37% over the previous quarter to $105.19 million.

Benzinga

Looking Into Seattle Genetics's Return On Capital Employed

According to Benzinga Pro data, during Q1, Seattle Genetics (NASDAQ:SGEN) posted sales of $426.46 million. Earnings were up 21.84%, but Seattle Genetics still reported an overall loss of $136.49 million.

Benzinga

Looking Into T. Rowe Price Group's Return On Capital Employed

Pulled from Benzinga Pro data, T. Rowe Price Group (NASDAQ:TROW) posted Q1 earnings of $514.40 million, an increase from Q4 of 29.88%. Sales dropped to $1.86 billion, a 5.05% decrease between quarters. T.

Benzinga

MACOM Technology's Return On Capital Employed Overview

According to Benzinga Pro data MACOM Technology (NASDAQ:MTSI) posted a 78.71% decrease in earnings from Q1. Sales, however, increased by 3.46% over the previous quarter to $165.15 million.

Benzinga

Looking Into TriMas's Return On Invested Capital

According to Benzinga Pro, during Q1, TriMas (NASDAQ:TRS) earned $14.17 million, a 10.53% increase from the preceding quarter. TriMas also posted a total of $224.31 million in sales, a 7.34% increase since Q4.

Benzinga

How To Attend Madrigal Pharmaceuticals Q1 2022 Earnings Conference Call

Madrigal Pharmaceuticals (NASDAQ:MDGL) will host a conference call at 08:00 AM ET on May 9, 2022, to discuss Q1 2022 earnings results.

1 … 636 637 638 639

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.